Entry Detail



General Information

Database ID:exR0364219
RNA Name:HLA-C
RNA Type:mRNA
Chromosome:chr6
Starnd:-
Coordinate:
Start Site(bp):31268749End Site(bp):31272130
External Links:ENSG00000204525



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ABCF1
chr6
30571393
30597179
+
AC005258.1
chr19
2269525
2341172
+
AC010323.1
chr19
8308283
8321379
-
AC015813.2
chr17
57989038
58007246
-
AC018523.2
chr11
14493783
14520344
-
AC024592.3
chr19
5866171
5903787
-
AC027644.4
chr7
66628958
66811189
+
AC087289.3
chr17
75898645
75930129
-
ACOT9
chrX
23701055
23766475
-
ACSS2
chr20
34872146
34927962
+
ACTB
chr7
5527148
5563784
-
ACTG1
chr17
81509971
81523847
-
ACTL6A
chr3
179562886
179588407
+
ACTR6
chr12
100199122
100241865
+
AD000671.1
chr19
35745678
35754519
+
ADA
chr20
44619522
44652233
-
ADD1
chr4
2843857
2930076
+
ADD3
chr10
109996368
110135565
+
ADORA2A
chr22
24417879
24442357
+
AFF1
chr4
86935002
87141054
+
AGPAT3
chr21
43865223
43987592
+
AHRR
chr5
271670
438291
+
AIMP1
chr4
106315544
106349456
+
AKR1A1
chr1
45550543
45570049
+
AKT1S1
chr19
49869033
49878459
-
AKT3
chr1
243488233
243851079
-
AL110118.2
chr14
93184973
93218586
+
AL133352.1
chr10
100505628
100529881
-
AL136295.5
chr14
24147548
24166452
+
AL928654.3
chr14
105487199
105492267
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-6891-3p
chr6
31355228
31355248
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC016876.2
chr17
7581964
7584086
-
AC093512.1
chr16
30064306
30064825
-
AC099329.1
chr3
42785087
42852428
-
AD000090.1
chr19
35557956
35581954
+
AF131216.4
chr8
11283481
11285068
-
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:17787
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.